Both in Pharmaceuticals
Aprea Therapeutics vs CNS Pharmaceuticals
Over the past year APRE returned −63.2% and CNSP returned −36.5%; their daily moves had a correlation of 0.05.
APRE −63.2% CNSP −36.5%Growth of $1, one year, split-adjusted
| Metric | APRE | CNSP |
|---|---|---|
| Price | $0.5150 | $4.55 |
| Market cap | $6.5M | $6.6M |
| Today | +4.89% | +3.64% |
| 1 month | −23.8% | −14.2% |
| 6 months | −38.9% | −36.4% |
| Year to date | −39.6% | −13.3% |
| 1 year | −63.2% | — |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 1,250.6× | — |
| Net cash | $41.2M | $20.0M |
| Dividend yield | — | — |
| Volatility (60d) | 96.0% | 73.6% |
| Short % of float | 5.9% | 0.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).